Literature DB >> 19197115

Fabrication of graded TiN coatings on nitinol occluders and effects on in vivo nickel release.

Deyuan Zhang1, Zhiwei Zhang, Zhenjun Zi, Yanhong Zhang, Weijun Zeng, Paul K Chu.   

Abstract

A nano-structured TiN/Ti coating with a total thickness of 0.9 mum was deposited on nitinol cardiac occluders using the filtered multi-arc vacuum ion plating technique at less than 300 degrees C. The coating was composed of laminated TiN/Ti layers with thickness of about 100 nm. The cardiac occluders made of a nitinol mesh with and without a graded nano-structured titanium nitride (TiN) coating were implanted into the hearts of rams. The nickel concentration of the whole blood of the animals were measured one week, one month, three months, and six months after implantation and compared to that before operation. The nickel concentration in the neo-endocardium covered occluders was also measured using graphite furnace atomic absorption spectrophotometry. After one week, the nickel content in the blood increased by a factor of three compared to the level before operation and decreased afterwards returning to the normal level after six months when endothelialization was complete. Statistical analyses showed that the TiN coating could mitigate nickel release into blood (P<0.01). For example, the nickel concentration released from the control increased from about 2.65+/-1.20 microg/kg, the normal concentration, to 7.30+/-1.00 microg/kg but just from 2.56+/-1.16 microg/kg to 4.68+/-1.29 microg/kg from the TiN coated occluder after 7 days. The nickel concentration in the neo-endocardium covered and TiN coated occluders reached 17.0+/-8.05 microg/kg in two months after implantation. In comparison, it was 31.0+/-5.72 microg/kg for the occluder without the TiN coating. While normal concentration of nickel in endocardium is also 2.6+/-1.09 microg/kg. Our results demonstrate that the graded TiN coating can significantly reduce nickel release into the endocardium (P<0.01) under in vivo conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19197115     DOI: 10.3233/BME-2008-0555

Source DB:  PubMed          Journal:  Biomed Mater Eng        ISSN: 0959-2989            Impact factor:   1.300


  7 in total

1.  Ceraflex versus Amplatzer occluder for secundum atrial septal defect closure. Multicenter clinical experience.

Authors:  M A Astarcioglu; M Kalcik; T Sen; A C Aykan; T Gokdeniz; O M Gursoy; S Karakoyun; S Kulahcioglu; S Gunduz; C Kilit; M Oylumlu; B Amasyali
Journal:  Herz       Date:  2015-02-08       Impact factor: 1.443

2.  Biocompatibility of new materials based on nano-structured nitinol with titanium and tantalum composite surface layers: experimental analysis in vitro and in vivo.

Authors:  Mikhail A Sevost'yanov; Elena O Nasakina; Alexander S Baikin; Konstantin V Sergienko; Sergey V Konushkin; Mikhail A Kaplan; Alexey V Seregin; Alexander V Leonov; Valery A Kozlov; Alexey V Shkirin; Nikolai F Bunkin; Alexey G Kolmakov; Sergey V Simakov; Sergey V Gudkov
Journal:  J Mater Sci Mater Med       Date:  2018-03-15       Impact factor: 3.896

3.  Comparison of Two Percutaneous Atrial Septal Defect Occluders for Device Healing and Nickel Release in a Chronic Porcine Model.

Authors:  Zakaria Jalal; Younes Boudjemline; Xavier Iriart; Pierre-Emmanuel Seguela; Samantha Delmond; Virgine Loyer; David Gonthier; Olivier Bernus; Marlène Durand; Laurence Bordenave; Jean-Benoit Thambo
Journal:  J Interv Cardiol       Date:  2020-06-20       Impact factor: 2.279

4.  Tulip deformity with Cera atrial septal defect devices: a report of 3 cases.

Authors:  Vikas Kohli
Journal:  Pediatr Cardiol       Date:  2014-09-02       Impact factor: 1.655

Review 5.  Role of animal models for percutaneous atrial septal defect closure.

Authors:  Zakaria Jalal; Pierre-Emmanuel Seguela; Alban-Elouen Baruteau; David Benoist; Olivier Bernus; Olivier Villemain; Younes Boudjemline; Xavier Iriart; Jean-Benoit Thambo
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

6.  Assessment of Device Neoendothelialization With Cardiac Computed Tomography Angiography After Transcatheter Closure of Atrial Septal Defect.

Authors:  Ah Young Kim; Wongi Woo; Beom Jin Lim; Jo Won Jung; Jae Young Choi; Young Jin Kim
Journal:  Circ Cardiovasc Imaging       Date:  2022-07-19       Impact factor: 8.589

7.  A comparison of the in vivo neoendothelialization and wound healing processes of three atrial septal defect occluders used during childhood in a nonrandomized prospective trial.

Authors:  Derya Aydın Şahin; Osman Başpınar; Ayşe Sülü; Tekin Karslıgil; Seval Kul
Journal:  Anatol J Cardiol       Date:  2017-07-25       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.